Pharmaceutical / Drug Definition :
Binds with serotonin 5-HT1B receptors on intracranial blood vessels and serotonin 5-HT1D receptors on sensory nerve endings, constricting cranial arteries and thereby relieving migraine
FDA Label Requirements and Exceptions
Eletriptan Hydrobromide
FDA Import Information
Eletriptan Hydrobromide
FDA Detentions
Eletriptan Hydrobromide (Eletriptan Hydrobromide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Eletriptan Hydrobromide (Eletriptan Hydrobromide Suppliers)
- Processors Eletriptan Hydrobromide
- Repackers Eletriptan Hydrobromide
- Relabelers Eletriptan Hydrobromide
- Exporters Eletriptan Hydrobromide
- Importers Eletriptan Hydrobromide
For more information about Eletriptan Hydrobromide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
